AU2001230869A1 - Ethanol solvate of - Google Patents

Ethanol solvate of

Info

Publication number
AU2001230869A1
AU2001230869A1 AU2001230869A AU3086901A AU2001230869A1 AU 2001230869 A1 AU2001230869 A1 AU 2001230869A1 AU 2001230869 A AU2001230869 A AU 2001230869A AU 3086901 A AU3086901 A AU 3086901A AU 2001230869 A1 AU2001230869 A1 AU 2001230869A1
Authority
AU
Australia
Prior art keywords
ethanol solvate
solvate
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001230869A
Other languages
English (en)
Inventor
Kurt M. Kesseler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of AU2001230869A1 publication Critical patent/AU2001230869A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AU2001230869A 2000-01-18 2001-01-08 Ethanol solvate of Abandoned AU2001230869A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48781500A 2000-01-18 2000-01-18
US09487815 2000-01-18
PCT/US2001/000520 WO2001053294A1 (en) 2000-01-18 2001-01-08 Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one

Publications (1)

Publication Number Publication Date
AU2001230869A1 true AU2001230869A1 (en) 2001-07-31

Family

ID=23937213

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001230869A Abandoned AU2001230869A1 (en) 2000-01-18 2001-01-08 Ethanol solvate of

Country Status (26)

Country Link
EP (1) EP1252155B1 (xx)
JP (1) JP2003520798A (xx)
KR (1) KR100825530B1 (xx)
CN (1) CN1395577A (xx)
AR (1) AR027226A1 (xx)
AT (1) ATE284400T1 (xx)
AU (1) AU2001230869A1 (xx)
BR (1) BR0107724A (xx)
CA (1) CA2397594C (xx)
CZ (1) CZ301235B6 (xx)
DE (1) DE60107652T2 (xx)
DK (1) DK1252155T3 (xx)
EA (1) EA005182B1 (xx)
ES (1) ES2228800T3 (xx)
HU (1) HU225155B1 (xx)
IL (2) IL150643A0 (xx)
MX (1) MXPA02006965A (xx)
NO (1) NO322626B1 (xx)
NZ (1) NZ520281A (xx)
PL (1) PL201690B1 (xx)
PT (1) PT1252155E (xx)
SI (1) SI1252155T1 (xx)
SK (1) SK287216B6 (xx)
TW (1) TWI293072B (xx)
WO (1) WO2001053294A1 (xx)
ZA (1) ZA200205640B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102466192B1 (ko) 2016-08-23 2022-11-14 에자이 알앤드디 매니지먼트 가부시키가이샤 간세포성 암종의 치료를 위한 조합 요법
WO2018170447A1 (en) 2017-03-16 2018-09-20 Eisai R&D Management Co., Ltd. Combination therapies for the treatment of breast cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (xx) * 1986-04-11 1989-02-04 Hoechst India
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
DE3836676A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
US5908934A (en) * 1996-09-26 1999-06-01 Bristol-Myers Squibb Company Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs

Also Published As

Publication number Publication date
PT1252155E (pt) 2005-04-29
ES2228800T3 (es) 2005-04-16
ZA200205640B (en) 2003-11-26
PL355992A1 (en) 2004-05-31
IL150643A (en) 2009-08-03
CZ301235B6 (cs) 2009-12-16
ATE284400T1 (de) 2004-12-15
AR027226A1 (es) 2003-03-19
NO20023385D0 (no) 2002-07-12
KR100825530B1 (ko) 2008-04-25
SK287216B6 (sk) 2010-03-08
EA200200776A1 (ru) 2002-12-26
CA2397594A1 (en) 2001-07-26
MXPA02006965A (es) 2004-09-06
NO20023385L (no) 2002-08-27
IL150643A0 (en) 2003-02-12
DK1252155T3 (da) 2005-04-04
TWI293072B (en) 2008-02-01
EP1252155A1 (en) 2002-10-30
HU225155B1 (en) 2006-07-28
HUP0204297A3 (en) 2005-04-28
CZ20022467A3 (cs) 2002-10-16
JP2003520798A (ja) 2003-07-08
WO2001053294A1 (en) 2001-07-26
DE60107652D1 (de) 2005-01-13
CA2397594C (en) 2010-03-23
PL201690B1 (pl) 2009-04-30
EP1252155B1 (en) 2004-12-08
DE60107652T2 (de) 2005-12-22
HUP0204297A2 (hu) 2003-04-28
CN1395577A (zh) 2003-02-05
KR20020069514A (ko) 2002-09-04
BR0107724A (pt) 2002-10-01
NZ520281A (en) 2004-04-30
SI1252155T1 (en) 2005-06-30
EA005182B1 (ru) 2004-12-30
SK10372002A3 (sk) 2002-12-03
NO322626B1 (no) 2006-11-06

Similar Documents

Publication Publication Date Title
AU2001280099A1 (en) 4-acylaminopyrazole derivatives
AU2001271027A1 (en) Ester derivatives
AU2001267766A1 (en) Pyrazole derivatives
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AU2002210409A1 (en) Ethanol process
AU2002363005A1 (en) Derivatives of uk-2a
AU2001235691A1 (en) Use of paullone derivatives for making medicines
AU2001294912A1 (en) Hydroxyesters of 7-desmethylrapamycin
AU2002234597A1 (en) Branched primary alcohol compositions and derivatives thereof
AU2001230537A1 (en) Pyridoxazine derivatives
AU2001256305A1 (en) Substituted pyrazole derivative
AU2001281802A1 (en) 6-phenylpyrrolopyrimidinedione derivatives
AU2001278790A1 (en) 1h-imidazopyridine derivatives
AU2385601A (en) Ethanol production
AU2001278694A1 (en) Avermectin derivatives
AU2002212301A1 (en) Diazacycloalkanedione derivatives
AU5256301A (en) Froindazole derivative
AU2002212959A1 (en) Cycloalkylfluorosulfonamide derivatives
AU2002215212A1 (en) 1-methylcarbapenem derivatives
AU2001289937A1 (en) Substituted 1-aminobutan-3-ol derivatives
AU2001254661A1 (en) Aminosulfonylbiphenyl derivatives
AU2001230565A1 (en) Perfluoroisopropylbenzene derivatives
AU2001234313A1 (en) Novel phenylheteroalkylamine derivatives
AU2001242772A1 (en) 3-substituted-4-pyrimidone derivatives
AU2001262489A1 (en) Triterpenoid derivatives